PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Mini-Plasco lidocaine hydrochloride
Presentation Product Chemical substance Chapter Items dispensed
Lidocaine 50mg/5ml (1%) inj Mini-Plasco ampoules (Hameln)
1502010J0BNAKBD
Mini-Plasco lidocaine hydrochloride Lidocaine hydrochloride Anaesthesia 193
Lidocaine 100mg/10ml (1%) inj Mini-Plasco ampoules (B.Braun)
1502010J0BNAFBW
Mini-Plasco lidocaine hydrochloride Lidocaine hydrochloride Anaesthesia 146
Lidocaine 100mg/5ml (2%) inj Mini-Plasco ampoules (Hameln)
1502010J0BNAICB
Mini-Plasco lidocaine hydrochloride Lidocaine hydrochloride Anaesthesia 97
Lidocaine 200mg/10ml (2%) inj Mini-Plasco ampoules
1502010J0BNAACE
Mini-Plasco lidocaine hydrochloride Lidocaine hydrochloride Anaesthesia 50
Lidocaine 100mg/10ml (1%) inj Mini-Plasco ampoules (Hameln)
1502010J0BNAJBW
Mini-Plasco lidocaine hydrochloride Lidocaine hydrochloride Anaesthesia 48
Lidocaine 50mg/5ml (1%) inj Mini-Plasco ampoules (B.Braun)
1502010J0BNABBD
Mini-Plasco lidocaine hydrochloride Lidocaine hydrochloride Anaesthesia 29
Lidocaine 200mg/20ml (1%) inj Mini-Plasco ampoules
1502010J0BNAECJ
Mini-Plasco lidocaine hydrochloride Lidocaine hydrochloride Anaesthesia 16
Lidocaine 100mg/5ml (2%) inj Mini-Plasco ampoules (B.Braun)
1502010J0BNACCB
Mini-Plasco lidocaine hydrochloride Lidocaine hydrochloride Anaesthesia 15
Lidocaine 400mg/20ml (2%) inj Mini-Plasco ampoules
1502010J0BNAHCU
Mini-Plasco lidocaine hydrochloride Lidocaine hydrochloride Anaesthesia 10
Lidocaine 40mg/2ml (2%) inj Mini-Plasco ampoules
1502010J0BNADBE
Mini-Plasco lidocaine hydrochloride Lidocaine hydrochloride Anaesthesia No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.